Common TitlePACTG 386
Official Title A Phase I Trial of the Safety and Pharmacokinetics of Fortovase (Saquinavir-SGC) Co-Administered With Low Dose (Ritonavir) RTV, ZDV and 3TC in HIV Seropositive Pregnant Women During Gestation and Postpartum, and in Their Infant's Post-Maternal Dosing
Phase Phase I
ClinicalTrials.gov NCT00000920
Treatments
Saquinavir
Saquinavir
Tradename:InviraseOther Names:SQVClass:Protease Inhibitors (PI)Categories PharmacologyPregnancy/WomenTreatment-NaiveTreatment-ExperiencedDrug Interactions
Funding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)
References
- Acosta EP, Bardeguez A, Zorrilla CD, et al. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2004;48:430-6.